FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/04/2026
Voltar para busca
Dado oficial do USPTO
90 DAYS TO RNA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
90 DAYS TO RNA
ST13
US500000079370272Classe
9, 16, 25, 38, 41
Pedido
79370272
Registro
7942987
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
62
Atualização mais recente
17/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 16, 25, 38, 41
Data de depósito
10/11/2022
Data de registro
16/09/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/09/2025
Última transação
17/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
maharashtra, IN
Examinador
FAIRBANKS, RONALD L
Localização atual
Historical data usage
Titulares e representantes
Titulares
POPVAX PRIVATE LIMITED
POPVAX PRIVATE LIMITED
Representantes
Lauren K. Tagarao Renner, Otto, Boisselle & Sklar, LLP
Classificação técnica
Classes Nice
Classe 9Classe 16Classe 25Classe 38Classe 41
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable software for use in designingmodellinganalysisdata analysisdata managementmodificationpredictionoptimization of structurefunctionsequencedynamicsstabilitythermodynamics of nucleic acidspolynucleotidesoligonucleotidesproteinsantigensimmunogensantibodiesnanobodiesdrug conjugatesligandspeptidesamino acidsnucleotidesnucleosidescarbohydratesadjuvantsdrug delivery carrierslipidspolymersformulationsdownloadable software for creatingmanaginganalyzingprocessing data related to researchdevelopmentmanufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of healthcaredisease management; downloadable software for controllingoptimizationcalibrationmaintenancediagnosticstroubleshooting of bioprocess systemsequipmentstoolsapparatus namely mixing devicesmicrofluidic devicesmicro-mixing devicesmixing vesselsfiltration systemsfermenters or bioreactorsliquid handling systemsseparation systemspurification systemschromatography systemsformulation systemsanalytical systemscharacterization systemsfilling systemlyophilisation systemspray drying systemencapsulation systempumpspressure vesselssensorsactuatorsflow controllerscontrol system for fluidicsautomated control systemsrobotic systemssynthesis systemsthermocyclersdownloadable software for use in designingmodellinganalysisdata analysisdata managementmodificationpredictionoptimization of experiments related to molecular biologycell biologybiochemistryorganic chemistryinorganic chemistrybiophysicsimmunologysequencingtoxicologypharmacodynamicspharmacokineticsbiodistributionformulationdrug deliverybioassaysanalytical assaysanalytical characterizationimmunological assaysneutralization assays for production or manufacturing of pharmaceutical and biopharmaceutical preparations for use in the fields of management of health or disease; pre-recorded audio-visual and multimedia products in the nature of cassettesaudiotapesvideotapesCDsDVDsCD-ROMshigh-capacity optical discsportable storage devices in the fields of healthcaredisease managementpharmaceuticals and medical developments; downloadable podcasts in the field of pharmaceuticalsvaccinesmedicinesbiologicsbiotherapeutics and biosimilars
Classe 16
Printed matternewslettersbulletinsmagazinesperiodicalsbooksjournalspamphletspostersstationery items in the nature of calendarspenspencilsnotepadswriting padsfoliosstickersbookmarkspocket sized cards featuring information and messagesall in the field of health caredisease managementpharmaceuticals and medical developments
Classe 25
Clothingjacketsjerseysshirtst-shirts; Indian ethnic wearkurtakurti; Clothingpyjamaapronslab coatsscarfspantsshortsblazerswristbandsglovesfingerless glovessocksbandanaarm sleeves worn separate and apart from blousesshirts and other topsclothing beltscapesknitwear in the nature of knitted topsjerseyst-shirtsjumpers in the nature of coverallspulloverscardigansscarfssocksheadbandshoodieshatsfoulards being clothingneckerchiefscarfface masks being headwearsportswear in the nature of sweatpantsswimwearathletic wear in the nature of shorts and t-shirtsfootwear; headgearhatsknitted capsvisors; headweart-shirtsouter jacketsjerseys being clothingcaps being headwearaprons.
Classe 38
Communications by computer terminals; communications by fibre optic networks; providing online forums; streaming of data; live streaming of events through telecommunication means; transmission of podcasts; wireless broadcasting; communications and telecommunicationstransmission of podcaststransmission of voicedatagraphicsimagesaudio and video by means of telecommunications networkswireless communication networksthe internet in the field of healthpharmaceuticalsvaccinesmedicinesbiologicsbiotherapeuticsbiosimilars; transmission of information for others relating to healthcommunication of information for patients or health professionals via computersinternettelevision and other digital means; Providing multiple use access to global computer information networks for the transfer and dissemination of information concerning scientificbiologicalmedical researchresearch and development of new productshealth care; Providing internet chatroom and online forums featuring information concerning scientificbiologicalmedical researchresearch and development of new productshealth care; Transmission of audio-visual information concerning scientificbiologicalmedical researchresearch and development of new productshealth care via electronic communications networks.
Classe 41
Educational servicesdevelopment and dissemination of printed and printed educational materials of others in the field of pharmaceuticalsvaccinesmedicinesbiologicsbiotherapeutics and biosimilars; conducting seminarslive events for educational purposeswebinarstalk showsweb or television seriesproduction of podcasts all in the field of pharmaceuticalsvaccinesmedicinesbiologicsbiotherapeutics and biosimilars; training services for patient support and education services in the nature of courses relating to prevention and treatment of medical disorders.
Publicações
Histórico de despachos e eventos da marca no USPTO.
62 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/03/2026
FIMP
FINAL DISPOSITION PROCESSED
27/03/2026
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/01/2026
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
17/12/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/12/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
26/09/2025
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
18/09/2025
APET
ASSIGNED TO PETITION STAFF
16/09/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/09/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
16/09/2025
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
31/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/07/2025
PUBO
PUBLISHED FOR OPPOSITION
29/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/07/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
24/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/05/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/05/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
14/04/2025
GNFR
FINAL REFUSAL E-MAILED
14/04/2025
CNFR
FINAL REFUSAL WRITTEN
14/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/04/2025
ATRV
ATTORNEY REVIEW COMPLETED
08/03/2025
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
26/02/2025
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
26/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2025
GNRT
NON-FINAL ACTION E-MAILED
12/01/2025
CNRT
NON-FINAL ACTION WRITTEN
12/01/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/01/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/11/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/11/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/10/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
23/10/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
18/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
18/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/10/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/05/2024
GNRT
NON-FINAL ACTION E-MAILED
16/05/2024
CNRT
NON-FINAL ACTION WRITTEN
16/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/03/2024
RFNT
REFUSAL PROCESSED BY IB
11/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
20/09/2023
RFRR
REFUSAL PROCESSED BY MPU
20/09/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
31/08/2023
CNRT
NON-FINAL ACTION WRITTEN
30/08/2023
DOCK
ASSIGNED TO EXAMINER
24/08/2023
MAFR
APPLICATION FILING RECEIPT MAILED
30/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/05/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace 90 DAYS TO RNA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.